sBioMed: Sterilant/Sporicide Kills MRSA, Anthrax and Other Pathogens in Record Time

OREM, Utah--(BUSINESS WIRE)--

STERIPLEX® Health Care (HC) (http://www.steriplex.net) is a new Sterilant/Sporicide, Tuberculocide, and Bactericide, which has recently received Federal EPA Registration. STERIPLEX® HC sets new standards, killing MRSA, spores and other pathogens in a fraction of the time of competing products while remaining safe to people and the environment.

Independent GLP certified laboratories have verified that STERIPLEX® HC destroys the most virulent pathogens including C. sporogenes and B. subtilis spores 10 to 32 times faster than other sterilant brands. Virulent spores are some of the toughest germs to kill. A sporicide will typically destroy all other germ species as well.

How safe is safe?

• STERIPLEX® HC is completely non-toxic, non-corrosive, non-flammable and 100% biodegradable.
• STERIPLEX® HC can safely be used as a non-critical care instrument soak and to disinfect all hard surfaces.

As germs like MRSA, C. diff. and anthrax become increasingly life-threatening, the war on superbugs continues as biotechnology companies from around the world race to produce products that kill germs effectively, without harming people or the environment. And, while consumers become evermore aware of product safety, harsh chemical disinfectants are out; Green, safe and effective is definitely in.

Competing sterilants have performance problems and/or serious corrosion and toxic side effects. Glutaraldehyde is a widely used sterilant in medical facilities, but it is highly toxic because of its many adverse side effects.

For example:

• Glutaraldehyde was banned in Great Britain several years ago.
• Chlorine-based products are extremely corrosive and harmful if inhaled or swallowed.
• Alcohol-based products, which offer only modest antimicrobial performance, disintegrate plastics and are harmful if inhaled or swallowed.

The new spore testing benchmarks required by the EPA to achieve sterilant (sporicidal) registration are far more rigorous today than the testing required of previously approved chemical sporicides.

The new EPA spore testing protocols required STERIPLEX® HC to be tested against spore concentrations of 100 times previous testing levels. Even so, STERIPLEX® HC passed all testing in record time. EPA Registration #84545-5 was issued to sBioMed™ November 2, 2009.

STERIPLEX® HC is registered as a broad spectrum Sterilant/Sporicide, Tuberculocide, and Bactericide. (http://www.sbiomed.com/products.php)

The current EPA registration of STERIPLEX® HC designates use as a hard surface sterilant. Future applications of the safe STERIPLEX® technologies could include uses in state-of-the-art disinfection products for hospitals, schools, food processing, and antimicrobial cleaning products and even topical surgical prep and burn center treatments.

Seven U.S. patents have already been issued to sBioMed® and seven more U.S. patents are being processed for issuance. All patents have been filed globally.

Next sBioMed® Product

sBioMed® also recently completed the successful testing of its bioweapons grade product, STERIPLEX™ Ultra. Brigham Young University’s Level III laboratory and the military’s bioweapons laboratory at Dugway Proving Grounds in Utah have certified STERIPLEX™ Ultra to completely destroy anthrax spores in less than 30 seconds using suspension test methods and only 30 minutes using AOAC carrier protocols. EPA registration of STERIPLEX® Ultra is expected in the next few months. (http://www.sbiomed.com/company.php)